The IFI44L gene helps control how cells respond to interferon, an early immune alarm signal that supports the body’s defense against infections, especially viruses. This gene plays an important role in keeping immune activity balanced so the response is strong enough to help, but not overly disruptive. If the IFI44L gene does not work properly, some people may be more prone to repeated infections, often in the airways, and can have signs of immune system imbalance.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or manage processes throughout the body. Some provide the code for proteins, which do much of the cell’s work. Others mainly regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, and medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
IFI44LGene function
What if the gene works
The IFI44L gene helps the body’s early antiviral defense. It is switched on by interferons, which are immune signals, and supports how cells respond to viral infection.
Risk
What if the gene does not work
If the IFI44L gene works less well, interferon driven antiviral signaling can weaken, and cells may control some viral replication less effectively. Milder and more severe variants can reduce this effect to different degrees.
Treatment
What does that mean for your treatment
No treatment or drug choice is currently guided specifically by a pathogenic or loss of function variant in the IFI44L gene. The IFI44L gene is being studied mainly as a biomarker of interferon activity, especially in lupus and some infections, rather than as a target for established gene-specific therapy.
Gene function
What if the gene works
When your body senses a virus, many cells quickly switch on the IFI44L gene. It is part of the early interferon response, one of the immune system’s fast warning signals. Understanding what the IFI44L gene does helps explain how cells prepare for viral threats and coordinate a measured defense.
Cells turn on the IFI44L gene in response to interferon, an immune alarm signal released during viral threats. This helps the body shift into an early defense mode.
This gene is part of a larger virus defense program that makes cells less welcoming to viruses. In everyday terms, it helps nearby cells get ready before a virus spreads further.
Its activity rises alongside other interferon response genes so immune actions happen in step. This coordinated timing supports an organized response across different tissues.
What is a variant?
A genetic variant is a small change in a gene’s DNA sequence. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the IFI44L gene can alter how much IFI44L protein a cell makes or can make the protein less stable, so it is broken down sooner. In this way, IFI44L gene variants may weaken how the protein folds, lasts, or interacts with other parts of the cell’s antiviral response. Some variants have milder effects that only partly reduce activity, while more disruptive variants can greatly lower protein production or leave little to no working protein.
How variants are linked to conditions
Research on how variants in the IFI44L gene are linked to conditions is still developing, and IFI44L does not yet have a broadly confirmed link to a specific health condition. Anyone with a confirmed IFI44L-related diagnosis should rely on guidance from their doctor or genetic counselor rather than general information.
A variant is not necessarily a diagnosis
Variants in genes are a usual part of being human and are widely found across the general population. Most do not directly affect health and instead reflect normal human variation. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also contribute. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't broadly confirmed evidence on specific factors that increase or reduce risk related to IFI44L. Anyone concerned about personal risk, especially in the context of autoimmune illness such as lupus, should discuss their family history and overall health with a doctor or genetic counselor.
Inheritance of IFI44L variants
There is not yet a broadly confirmed IFI44L inheritance pattern tied to a specific human condition, and this picture may become clearer as research grows. For families asking how IFI44L gene variants are inherited, the most accurate answer is that no single disease specific pattern, such as autosomal dominant or autosomal recessive, is firmly established for this gene at this time. The IFI44L gene is located on chromosome 1, which is an autosome, so each person inherits one copy from each parent.
What does my IFI44L result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific condition for IFI44L. Research on this gene is still developing, so a result in IFI44L does not by itself give a clear, standard answer about what it means for relatives. If you have a specific IFI44L finding, the family impact depends on the exact result and why the test was done.
Genetic information
Genetic testing
How you find out about variants
IFI44L genetic testing looks for variants in the IFI44L gene using a blood or saliva sample. A lab reads the DNA code and compares it with the usual sequence to see whether a variant is present. Results may show no relevant variant, a known disease-linked variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
There is not yet a broadly established, IFI44L-specific clinical reason for genetic testing. Decisions about testing are usually made with a doctor or genetic counselor based on your health history, symptoms, and family history.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and on the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also influence how the body functions. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, genetic results may also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, seems less helpful for another, or causes more side effects in someone else. Part of the difference comes from inherited changes that influence how the body absorbs, breaks down, transports, or responds to a drug, and this kind of variation is common.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way someone responds to medications. By looking at relationships between genes and drugs, it helps clarify why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body processes it. This information can support more informed, individualized treatment decisions. To explore this topic in greater detail, you can learn more in the LearnHub.
Drugs influenced by the IFI44L gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so general questions about medicines, side effects, or treatment changes are best discussed with your doctor.
History
IFI44L entered the research literature during large gene-mapping efforts in the late 1990s and early 2000s, when scientists were cataloging genes switched on by interferon during infection. It drew wider attention as studies of immune activity repeatedly found IFI44L among the genes that changed strongly in response to viral illness. From these first observations, research expanded steadily. In the 2010s, IFI44L became especially notable in biomarker studies, including work on lupus and on blood test patterns that may help separate viral from bacterial infections. Its history is tied less to a single breakthrough and more to growing recognition of how gene activity patterns can guide diagnosis and immune research.